| DC11533 |
PH-46A N-Methyl-D-Glucamine salt |
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.. |
|
| DC11532 |
PH-46A |
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.. |
|
| DC23211 |
SKF 82958
Featured
|
A potent, full dopamine D1 agonist. |
|
| DC20939 |
NCGC00379308
Featured
|
A potent, functionally selective TSH receptor (TSHR) positive allosteric modulator with EC50 of 11.6 uM (β-Arr 1 translocation). |
|
| DC23958 |
MRK-016 |
A potent, functionally selective, CNS-penetrating and orally bioavailable inverse agonist of benzodiazepine site of GABAA α5 receptor with Ki of 0.8-1.5 nM for α1-, α2-, α3-, andα5-containing GABAA receptors. |
|
| DC20599 |
25CN-NBOH |
A potent, highly selective and brain-penetrant 5-HT2A receptor agonist with Ki of 1.1 nM ([3H]ketanserin). |
|
| DC20773 |
BI-853520 |
A potent, highly selective and orally active inhibitor of PTK2/FAK with IC50 of 1 nM in cell-free assays. |
|
| DC25066 |
NVP-BDZ 824 |
A potent, highly selective antagonist of chemokine receptor CXCR3 with binding IC50 of 146 nM, Ca2+-mobilization IC50 of 28 nM.. |
|
| DC21484 |
PF-04802367
Featured
|
PF04802367 is a potent, highly selective GSK-3 inhibitor with IC50 of 2.1 nM for human GSK-3β in enzyme assays; shows equal effectivity against GSK-3α and GSK-3β with IC50 of 10.0 and 9.0 nM respectively in mobility shift assays, inhibits phosphorylation of tau with an IC50 of 466 nM in a stable inducible CHO cell line over-expressing GSK-3β and substrate tau; modulates tau phosphorylation in vitro and in vivo. |
|
| DC20794 |
BIO-5192 |
A potent, highly selective inhibitor of integrin α4β1 (VLA-4) with Kd of <10 pM, IC50 of 1.8 nM. |
|
| DC22760 |
JJKK-048 |
A potent, highly selective monoacylglycerol lipase (MAGL) with IC50 of <0.4 nM against human and rodent MAGL. |
|
| DC20501 |
PI3Kβ and δ inhibitor 20a |
A potent, highly selective PI3Kβ/δ inhibitor with IC50 of 7.8/5.3 nM respectively, with liitle to no activity on PI3Kα/γ (IC50=850/>10,000 nM). |
|
| DC24046 |
VTP-27999 hydrochloride |
A potent, highly selective renin inhibitor with IC50 of 0.47 nM. |
|
| DC22610 |
VTP-27999 2,2,2-trifluoroacetate |
A potent, highly selective renin inhibitor with IC50 of 0.47 nM. |
|
| DC22866 |
BIO-7662 |
A potent, highly selective α4β1 integrin antagonist with Kd of <10 pM. |
|
| DC21257 |
LY2780301
Featured
|
The compound you are referring to is likely a dual inhibitor of p70S6K (S6K1) and Akt, two critical kinases in the PI3K/Akt/mTOR signaling pathway. This pathway is a central regulator of cell growth, proliferation, survival, and metabolism, and its dysregulation is frequently observed in cancers, including solid tumors and non-Hodgkin's lymphoma (NHL). A dual inhibitor targeting both p70S6K and Akt would offer a powerful therapeutic strategy to block this pathway at multiple nodes, potentially overcoming resistance mechanisms and improving treatment outcomes.
|
|
| DC24003 |
TC-S 7001(Azaindole 1)
Featured
|
A potent, highly selective, ATP-competitive ROCK inhibitor with IC50 of 0.5/1.1 nM for ROCK1/ROCK2 respectively. |
|
| DC26096 |
SR-8993 |
A potent, highly selective, brain-penetrant NOP-R (Nociceptin/orphanin FQ receptor) agonist with EC50 of 8.8 nM. |
|
| DC20316 |
Bantag-1 trifluoroacetate
Featured
|
A potent, highly selective, peptide bombesin receptor subtype-3 (BRS-3) antagonist with IC50 of 2-8 nM for human and rodent BRS-3, displays 1000-fold selectivity over hNMBR and hGRPR, increases food intake and produces an obesity phenotype in mice.. |
|
| DC21861 |
Z-DON |
A potent, irreversible and cell permeable inhibitor of tissue transglutaminase with IC50 of 20 nM.. |
|
| DC21216 |
L 682777 |
A potent, irreversible inhibitor of human tissue transglutaminase (hTG2).. |
|
| DC23777 |
R 283 |
A potent, irreversible inhibitor of human tissue transglutaminase (hTG2).. |
|
| DC21001 |
Estrone sulfamate |
A potent, irreversible, and orally active inhibitor of steroid sulfatase (STS) with IC50 of 65 pM in intact MCF-7 cells. |
|
| DC22880 |
MIV-6R |
A potent, ligand-efficient, and cell-active inhibitor menin-MLL interaction with IC50 of 56 nM, Kd of 85 nM. |
|
| DC22383 |
Sitaxsentan |
A potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM. |
|
| DC23661 |
Evogliptin |
A potent, long acting, reversible and competitive DPP-4 inhibitor with IC50 of 0.9 nM. |
|
| DC22890 |
Frovatriptan
Featured
|
A potent, long lasting 5-HT(1B/1D) receptor agonist as a antimigraine agent.. |
|
| DC22812 |
CEP-11981 |
CEP-11981 is a potent, multi-targeted, orally active, pan-VEGFR, TIE-2 and FGFR1 inhibitor with IC50 of 3-100 nM. |
|
| DC22851 |
IDI-6273 |
A potent, mutant-selective PfDHODH inhibitor with IC50 of 210 nM for 3D7 E182D PfDHODH. |
|
| DC20946 |
DD-01050 |
A potent, noncompetitive TRPV1 antagonist that abrogates capsaicin and pH-evoked TRPV1 channel activity with submicromolar activity. |
|
